New recommendations prioritise multiparametric MRI, safer transperineal biopsy, and earlier escalation for high-risk prostate-specific antigen relapse.

Decades ago, doctors created a test to determine which breast cancer patients should receive hormone therapy. Now, researchers are using the same tactics to advance prostate cancer treatment.

The global statistics are terrifying. Prostate cancer is the fourth most common cancer in all populations, the second most common cancer among men worldwide, and ranks first in Europe, where a third ...

Doctors began testing PSA levels in the 1980s to monitor diagnosed cancers. By the early 1990s, researchers promoted it for ...

Screening for prostate cancer becomes more complex in men over the age of 70. The US Preventive Services Task Force (USPSTF) currently recommends against routine PSA testing in this age group. The PSA ...

Prostate cancer has overtaken breast cancer to become the most common form of the disease in the UK for the first time.

Patients will be able to find out whether they have genes linked to cancer using a world-leading tool developed by the NHS.

DENVER (KDVR) — Prostate cancer is the second most common cancer among U.S. men, behind only lung cancer, according to the American Cancer Society. An estimated 300,000 men will be diagnosed with ...

Staging means finding out how far prostate cancer has spread in your body. Physicians group prostate cancers into stages I (1) through IV (4), with stage I being the least advanced and stage IV being ...

Prostate cancer is a type of cancer that starts in the prostate gland, that helps make semen. Most men don’t notice anything ...